Noninvasive technology for the high-throughput characterization of cancer cells

Monitoring cancer cells effectively can help physicians with treatment and management, thus reducing cancer-related mortality. Can non-invasive technologies pave the way for improved monitoring to reduce cancer mortality rates? Diagnostic platforms that non-invasively measure the electrical properties of cancer cells offer promise in the early detection of cancer drug resistance and metastasis.

Research team develops new technology for robotic prosthetic leg control

A research team led by Professor Sang-hoon Lee at the Department of Robotics and Mechatronics Engineering, Daegu Gyeongbuk Institute of Science and Technology has successfully developed an imperceptive surface electromyography (sEMG) sensor. The sensor is crucial in allowing lower limb amputees to control robotic prosthetic legs as they want and is expected to contribute greatly to rehabilitation and a better quality of life.

Hodgkin lymphoma prognosis, biology tracked with circulating tumor DNA

A Stanford Medicine-led, international study of hundreds of samples from patients with Hodgkin lymphoma has shown that levels of tumor DNA circulating in their blood can identify who is responding well to treatment and others who are likely to experience a disease recurrence—potentially letting some patients who are predicted to have favorable outcomes forgo lengthy treatment.

Prenatal exposure to GLP-1 receptor agonists and other second-line antidiabetics may not pose greater risk than insulin

Infants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) during pregnancy are at no higher risk of major congenital malformations (MCMs) than infants born to those who take insulin, according to a new study led by Harvard T.H. Chan School of Public Health.